We investigated the potential of a panel of 22
biomarkers to predict the presence of
coronary artery disease (CAD) in type 2diabetes mellitus (DM2)
patients. The study enrolled 96 DM2
patients with (n = 75) and without (n = 21) evidence of CAD.We assessed a biochemical profile that included 22
biomarkers total
cholesterol, LDL, HDL, LDL/HDL,
triglycerides,
glucose,
glycated hemoglobin,
fructosamine,
homocysteine,
cysteine,
methionine,
reduced glutathione,
oxidized glutathione, reducedglutathione/
oxidized glutathione,
L-arginine, asymmetric dimethyl-
L-arginine, symmetric dimethyl-
L-arginine, asymmetricdimethyl-
L-arginine/
L-arginine,
nitrate plus
nitrite,
S-nitrosothiols, nitrotyrosine, and n-acetyl-𝛽-
glucosaminidase. Predictionmodels were built using
logistic regression models.We found that eight
biomarkers (
methionine, nitratate plus
nitrite, n-acetyl-𝛽-
glucosaminidase, BMI, LDL, HDL,
reduced glutathione, and
L-arginine/asymmetric dimethyl-
L-arginine) along with
gender andBMI were significantly associated with the odds of CAD in DM2. These preliminary findings support the notion that emergingbiochemical markers might be used for CAD prediction in
patients with DM2. Our findings warrant further investigation withlarge, well-designed studies.